Canopy Growth Corporation (CGC) Stock Forecast and Price Target (2026)

Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. That is the situation with CGC. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model rather than a consensus.

Because Canopy is unprofitable, earnings multiples do not apply, and at about 1.1 times sales and well under book value the market is pricing in real doubt that the turnaround reaches profit. Reported financials are in Canadian dollars, so US-dollar comparisons move with exchange rates. Treat any single quarter with caution: cannabis results swing on pricing, one-time charges and restructuring, and the next report lands November 6, 2026.

For the fiscal year ending Mar 2027, the 4 analysts publishing estimates on CGC expect earnings of -0.07 CAD per share and revenue of 351.9 million CAD (+24%).

Estimates are the most widely published forecast there is: many more analysts model a company's earnings than publish a price target on it. They are also revised constantly, and the direction of those revisions into a report is often more informative than the level. Canopy Growth Corporation next reports on November 6, 2026, which is when these figures get tested against actual results.

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering CGC do not put out a 2030 number. Anything presenting one is extrapolating a growth rate rather than reporting research, and a figure produced that way tells you about the assumption chosen, not about the company.

What can be said over a long horizon is what the current price already assumes about the business, which is a question the filings answer and a forecast cannot.

That is the more useful frame for a ten-year question. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether Canopy Growth Corporation can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

In short: the drivers cited most often are Core cannabis business back to growth, MTL Cannabis and medical leadership, Balance-sheet reset and lower losses. The risk cited most often against it is the central risk is that Canopy is still unprofitable in a brutally competitive industry.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the CGC is it a buy page. This page deliberately stops at the numbers.